ACE Reports.
Make a selection below to explore our full database of 5 results on the topic: "RB Wagman"
ACE Reports
(5 Reports)ACE Reports
(5 Reports)
Metabolic Disorders
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Metabolic Disorders
Denosumab increases BMD and reduces bone turnover vs monthly oral bisphosphonate
Osteoporos Int. 2014 Jul;25(7):1953-61. doi: 10.1007/s00198-014-2692-7. Epub 2014 Mar 28.
Metabolic Disorders
WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy
General Orthopaedics
Denosumab reduces secondary fragility fracture risk in osteoporotic women
Climacteric. 2015 Jun 1:1-23
Metabolic Disorders
Denosumab increases bone mineral density in male patients with low BMD
J Clin Endocrinol Metab. 2012 Sep;97(9):3161-9. doi: 10.1210/jc.2012-1569. Epub 2012 Jun 21